Viewing Study NCT04330820


Ignite Creation Date: 2025-12-25 @ 4:18 AM
Ignite Modification Date: 2025-12-26 @ 3:19 AM
Study NCT ID: NCT04330820
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-02-28
First Post: 2020-03-19
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Trial for Relapsed or Refractory AML Patients Combining Cytarabine and Mitoxantrone With Venetoclax (RELAX)
Sponsor: Technische Universität Dresden
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module